718-1170

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2013-09-16

AEs

Serious

Dropout signal

–

Adverse events

severe assessed

Severe AGITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-16 (study day 31.0); relationship: POSSIBLE

mild assessed

Mild BODY TEMPERATURE INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

moderate assessed

Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-10-07 (study day 22.0); relationship: POSSIBLE

moderate assessed

Moderate HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

mild assessed

Mild HYPERTENSION — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

severe serious reported

Severe SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 27.0); relationship: PROBABLE; serious criteria: hospitalization

Data queries

No data queries.